were Gram-negative (Additional file 1: Figure S1 ). Of these 59 patients, 25 (42%) cases were community-acquired and 34 (58%) cases were nosocomial BM (Additional file 1: Table S1 ). Bacterial etiologies were presented in Additional file 1: Table S2 . All the participants had empiric antibiotic pretreatments before admission to our N-ICU. Demographics, severity, clinical characteristics, treatments, and the time from CSF-PCT test to onset of BM were balanced in Gram-positive group and Gram-negative group (Additional file 1: Table S3 ). The CSF-PCT level of Gram-negative patients was significantly higher than that of Gram-positive patients (0.5 [0.2-1.6] versus 0.1 [0.1-0.3] ng/ml, p < 0.001) ( Table 1 , Fig. 1 ). There were no significant differences of other biomarkers between Gram-positive and Gram-negative group (Additional file 1: Figure S2 ). CSF-PCT yielded an area under the curve (AUC) of 0.85 (95% CI, 0.73 to 0.93), which was superior to serum PCT, CSF/serum C-reactive protein (CRP) (Fig. 1) .
The early identification for the pathogenic bacteria of BM is of great importance to the rational use of antibiotics. However, meningitis with a negative Gram stain poses a diagnostic and therapeutic dilemma, especially in developing countries like China [4] . CSF and serum CRP were previously indicated to be associated with Gram-negative BM [5] , but in patients The CSF and serum samples were collected on the same day. Continuous variables were expressed as mean ± standard deviation (normally distributed), as medians and interquartile ranges (IQR, not normally distributed), which were compared using the Student t test or Mann-Whitney U test. The CSF and serum samples were collected on the same day CSF cerebrospinal fluid, PCT procalcitonin, CRP C-reactive protein with empiric antibiotic pretreatment, they were not informative any more. Our study indicated that CSF-PCT was a more robust and superior diagnostic biomarker for Gram-negative BM, even in patients who had received empiric antibiotic pretreatment.
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